تحميل
NASDAQHealthcareBiotechnology
أحدث البيانات المتاحة
4.20 US$
−0.17 US$ · -3.89%
Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully completed Phase II clinical trials for patients with diabetes. Oramed is also advancing ORMD-0901, an oral glucagon-like peptide-1 (GLP-1) capsule, which has concluded Phase I clinical trials for the treatment of type 2 diabetes. Additionally, an oral leptin capsule for weight loss is currently under development. The firm was originally incorporated as Integrated Security Technologies, Inc., before officially changing its name to Oramed Pharmaceuticals Inc. in April 2006.
عند الإغلاق
4.20 US$
−0.17 US$ · -3.89%
بعد ساعات التداول
4.20 US$
0.00 US$ · 0.00%
8 أكتوبر، 4:43 م ET
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully completed Phase II clinical trials for patients with diabetes. Oramed is also advancing ORMD-0901, an oral glucagon-like peptide-1 (GLP-1) capsule, which has concluded Phase I clinical trials for the treatment of type 2 diabetes. Additionally, an oral leptin capsule for weight loss is currently under development. The firm was originally incorporated as Integrated Security Technologies, Inc., before officially changing its name to Oramed Pharmaceuticals Inc. in April 2006.
نطاق اليوم
السعر الحالي 4.20 US$
نطاق 52 أسبوعًا
السعر الحالي 4.20 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
71
أقل من القيمة
المشاعر
64
صعودي
المخاطر
56
مخاطر أعلى من المعتاد
الزخم
56
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully completed Phase II clinical trials for patients with diabetes. Oramed is also advancing ORMD-0901, an oral glucagon-like peptide-1 (GLP-1) capsule, which has concluded Phase I clinical trials for the treatment of type 2 diabetes. Additionally, an oral leptin capsule for weight loss is currently under development. The firm was originally incorporated as Integrated Security Technologies, Inc., before officially changing its name to Oramed Pharmaceuticals Inc. in April 2006.
نطاق اليوم
السعر الحالي 4.20 US$
نطاق 52 أسبوعًا
السعر الحالي 4.20 US$
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
صناديق متداولة تفصح عن تعرضها لهذا السهم.
iShares Russell 2000 ETFIWM3.74 مليون0.00%78.56 مليار USD0.19%277.57 US$-0.05%
Vanguard Russell 2000 ETFVTWO986.17 ألف0.01%18 مليار USD0.06%112.1 US$-0.10%
iShares Micro-Cap ETFIWC476.23 ألف0.04%1.33 مليار USD0.60%182.79 US$-0.31%
Dimensional - US Small Cap ETFDFAS267.07 ألف0.00%33.66 مليار USD0.31%78.10 US$+0.23%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGSSC263.12 ألف0.03%1.04 مليار USD0.20%85.92 US$+0.21%
Dimensional - US Core Equity 2 ETFDFAC261.7 ألف0.00%88.28 مليار USD0.21%45.11 US$-0.15%
Avantis U.S. Small Cap Equity ETFAVSC243.07 ألف0.01%3.04 مليار USD0.25%69.96 US$+0.47%
Vanguard Russell 2000 Value ETFVTWV158.47 ألف0.01%1.4 مليار USD0.06%186.06 US$+0.59%iShares Russell 2000 ETFIWMVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCDimensional - US Small Cap ETFDFASGoldman Sachs ActiveBeta U.S. Small Cap Equity ETFGSSCDimensional - US Core Equity 2 ETFDFACAvantis U.S. Small Cap Equity ETFAVSCVanguard Russell 2000 Value ETFVTWVالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
